This study is a phase I trial research hub

An open label, randomized, single-dose, two-sequence, two-period, crossover comparative bioavailability study to assess the pharmacokinetic and safety profile of Dofetilide intravenous solution compared to Tikosyn® (Dofetilide) oral capsule in healthy subjects under fasting conditions.

This study is looking at how a heart medication called dofetilide works in the body. Researchers want to compare a new liquid form given directly into a vein with the usual capsule form, to see if they are absorbed similarly and are safe for healthy volunteers.